Skip to Content
Merck
  • Total Biosynthesis of the Pyrrolo[4,2]benzodiazepine Scaffold Tomaymycin on an In Vitro Reconstituted NRPS System.

Total Biosynthesis of the Pyrrolo[4,2]benzodiazepine Scaffold Tomaymycin on an In Vitro Reconstituted NRPS System.

Cell chemical biology (2017-09-12)
Alexander von Tesmar, Michael Hoffmann, Jan Pippel, Antoine Abou Fayad, Stefan Dausend-Werner, Armin Bauer, Wulf Blankenfeldt, Rolf Müller
ABSTRACT

In vitro reconstitution and biochemical analysis of natural product biosynthetic pathways remains a challenging endeavor, especially if megaenzymes of the nonribosomal peptide synthetase (NRPS) type are involved. In theory, all biosynthetic steps may be deciphered using mass spectrometry (MS)-based analyses of both the carrier protein-coupled intermediates and the free intermediates. We here report the "total biosynthesis" of the pyrrolo[4,2]benzodiazepine scaffold tomaymycin using an in vitro reconstituted NRPS system. Proteoforms were analyzed by liquid chromatography (LC)-MS to decipher every step of the biosynthesis on its respective megasynthetase with up to 170 kDa in size. To the best of our knowledge, this is the first report of a comprehensive analysis of virtually all chemical steps involved in the biosynthesis of nonribosomally synthesized natural products. The study includes experiments to determine substrate specificities of the corresponding A-domains in competition assays by analyzing the adenylation step as well as the transfer to the respective carrier protein domain.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Amino-5-hydroxybenzoic acid, 98%
Sigma-Aldrich
Kanamycin sulfate, mixture of Kanamycin A (main component) and Kanamycin B and C
Sigma-Aldrich
2-Amino-5-methoxybenzoic acid, 97%